Cybernetics

Ome Receives Venture Capital to Drive Strategic Growth

Retrieved on: 
Thursday, March 3, 2022
Cybernetics, Entrepreneurship, Technology, Safety, CEO, Solution, Industry, Software, Venture, Cryptocurrency

ATLANTA, March 3, 2022 /PRNewswire/ -- Today, Ome, Inc. (d/b/a "Ome") announced a strategic investment from Legendary Ventures, a venture capital firm that accelerates value creation for consumer retail technology companies.

Key Points: 
  • ATLANTA, March 3, 2022 /PRNewswire/ -- Today, Ome, Inc. (d/b/a "Ome") announced a strategic investment from Legendary Ventures, a venture capital firm that accelerates value creation for consumer retail technology companies.
  • Ome will use this investment to expedite new product development and expand into new retail markets leveraging their smart home technology solutions.
  • Ome develops smart, sustainable technology products that automate existing home appliances so families can spend more quality time together.
  • Legendary Ventures is a venture capital firm that accelerates value creation for early-stage startups in the consumer, retail, and technology industries.

Paul Chouffet Promoted to CISO & EVP of Product & Solution Engineering of VAZATA

Retrieved on: 
Thursday, March 3, 2022
Engineering, Product, Leadership, Health care, Organization, Solution, Growth, Bloomberg Businessweek, Compliance, CEO, Public sector, Cybernetics, Paul, CISO, CISSP, EVP, Cryptocurrency, Risk management, Technology

MCKINNEY, Texas, March 3, 2022 /PRNewswire-PRWeb/ -- VAZATA, a managed security services provider focused on data security, protection, and compliance , is pleased to announce the promotion of Paul Chouffet as CISO and EVP of Product & Solution Engineering.

Key Points: 
  • MCKINNEY, Texas, March 3, 2022 /PRNewswire-PRWeb/ -- VAZATA, a managed security services provider focused on data security, protection, and compliance , is pleased to announce the promotion of Paul Chouffet as CISO and EVP of Product & Solution Engineering.
  • In addition to expanding the VAZATA security product portfolio, Paul has developed a fractional CISO function for VAZATA's customers.
  • "My role as CISO and EVP of Solution Engineering will be to enhance both VAZATA's and VAZATA client's security posture in this ever-changing security landscape.
  • We look forward to working with Paul as he helps guide the growth of VAZATA, our clients, and our commitment to data protection," stated Lance Black, CEO, VAZATA.

Neo Cybernetica Secures $30M Seed Round Led by NEA

Retrieved on: 
Wednesday, February 9, 2022
Initial public offering, Artificial intelligence, Science, IPO, NEA, Technology, Neuroscience, Robotics, Pleasure, Learning, CEO, Chief executive officer, Cybernetics, Founder CEO, Machine learning, Communication, Achin, Management

BOSTON, Feb. 9, 2022 /PRNewswire/ -- Neo Cybernetica , a stealth deep tech company, today announced the close of a $30M seed round led by NEA, with additional participation from B5 Capital, Cortical Ventures, and Open Field Capital.

Key Points: 
  • BOSTON, Feb. 9, 2022 /PRNewswire/ -- Neo Cybernetica , a stealth deep tech company, today announced the close of a $30M seed round led by NEA, with additional participation from B5 Capital, Cortical Ventures, and Open Field Capital.
  • Achin, who is actively leading Neo Cybernetica as CEO, is joined on the founding team by Chief Technology Officer Dmytro Zahanych.
  • "Starting this company with Dmytro as my co-founder was an easy decision for me," said Achin.
  • Early DataRobot investor NEA is leading the funding round with DataRobot board director Tony Florence joining Neo Cybernetica's board of directors.

Imagia Cybernetics & Canexia Health Merge to Supercharge Precision Oncology Accessibility

Retrieved on: 
Wednesday, February 9, 2022
Technology, Medical Devices, Hospitals, Software, Biotechnology, Health, Pharmaceutical, Data Management, Oncology, Artificial intelligence, Community, BDC, Informatics, Woman, Ministry of Education (Malaysia), Time, Toshiba, Recurrence, Cancer, Oncology, Technology, Patient, Hospital, Privacy, Health, Organization, GE Healthcare, Therapy, Physician, Intelligence, Cybernetics, Genomics, Pharmaceutical industry, Medical imaging, Imagia Cybernetics, Canexia Health, IMAGIA CYBERNETICS, CANEXIA HEALTH

Imagia Cybernetics , an AI-healthcare company that accelerates oncology solutions generated from real world data, today announced its merger with Canexia Health .

Key Points: 
  • Imagia Cybernetics , an AI-healthcare company that accelerates oncology solutions generated from real world data, today announced its merger with Canexia Health .
  • Their expertise in genomics, oncology, artificial intelligence, and informatics will enable health systems to bring testing in-house, delivering precision oncology to patients no matter where they live.
  • The new company, Imagia Canexia Health, improves accessibility through cost-effective local testing, thereby reducing expenses and generating faster results.
  • Through Imagia Canexia Health these precision treatments can be available to physicians and patients around the world, said Canexia Health Board Chair Sue Paish, who will also chair the new company.

Tytan Cybernetics (“Video River Networks” OTC) Announces Plan to Conduct S-1 Registration of its Drive-Crypto-EV Token.

Retrieved on: 
Tuesday, December 7, 2021
Crypto, Company, GLOBE, Review, Energy Independence and Security Act of 2007, Electric vehicle, Business, OTC, Lawyer, Private Securities Litigation Reform Act, Artificial intelligence, News, CEO, Form, EVS, Drone, Sport, Cybernetics, Convenience, Advanced Battery Technologies, Securities Exchange Act of 1934, Machine learning, PCAOB, Mission statement, Securities Act of 1933, Certification, Cryptocurrency, Community, Operationalization

Following the counsel of our lawyers, we have decided to register our Drive-Crypto-EV Token using the Form S-1.

Key Points: 
  • Following the counsel of our lawyers, we have decided to register our Drive-Crypto-EV Token using the Form S-1.
  • stated Frank I Igwealor, CEO of Tytan Cybernetics/ Video River Networks.
  • Tytan Cybernetics recently announce plan to build out Charge-Stations throughout the United States, starting with California, through its subsidiary, American Electric Vehicles and Battery Technology, Inc.
  • With a commitment to revolutionary technology, Tytan Cybernetics is in the process of cultivating prosperous technologies to enhance consumers cybernetic experience.

Prevencio Announces U.S. Patent Issuance for Novel, Artificial Intelligence-driven Blood Test for Cardiac Risk

Retrieved on: 
Wednesday, August 4, 2021
Data Management, Medical Supplies, Health, Technology, Software, Cardiology, Biotechnology, Articles, Cybernetics, Academic disciplines, Emerging technologies, Artificial intelligence, Computational neuroscience, Machine learning, Heart, Cardiovascular disease, Prevencio HART Tests, Prevencio, Inc., PREVENCIO HART TESTS, PREVENCIO, INC.

Prevencio, Inc. today announces the United States Patent Offices issuance of a patent for its highly accurate blood test, HART CVE, for a patients one-year risk of heart attack, stroke, or cardiovascular death.

Key Points: 
  • Prevencio, Inc. today announces the United States Patent Offices issuance of a patent for its highly accurate blood test, HART CVE, for a patients one-year risk of heart attack, stroke, or cardiovascular death.
  • The company leveraged its Artificial Intelligence (AI)-driven HART platform and expertise in cardiac blood tests to develop HART CVE.
  • This patent issuance for HART CVE demonstrates the U.S. Patent Offices recognition of our novel invention for a machine learning-driven, multiple protein, algorithmically scored blood test for detection of adverse cardiac events, said Rhonda Rhyne, President and Chief Executive Officer of Prevencio.
  • For additional information, visit Prevencio, Inc.
    Powered by Artificial Intelligence (AI), Prevencio is revolutionizing blood tests for cardiovascular disease and custom diagnostics.

Driving Minnesota: Drive Appeal to Deploy Scienaptic’s AI Platform to Enhance Credit Accessibility

Retrieved on: 
Wednesday, August 4, 2021
Data Management, Banking, Accounting, Technology, Professional Services, Small Business, Other Technology, Software, Networks, Insurance, Finance, Articles, Academic disciplines, Computational neuroscience, Artificial intelligence, Cybernetics

Leading global AI-powered credit decision platform provider, Scienaptic AI announced that Drive Appeal has selected its AI-powered platform.

Key Points: 
  • Leading global AI-powered credit decision platform provider, Scienaptic AI announced that Drive Appeal has selected its AI-powered platform.
  • The implementation will enable Drive Appeal to approve more loans and enhance the used car financing experience.
  • Scienaptic's AI-powered platform is a fantastic fit for the AI roadmap we have in mind, said John Prosser, President, Drive Appeal.
  • Over 150 years of credit experience is embedded in Scienaptic's AI native credit decision platform.

Aragon Research Announces Special Report: Hot Vendors Part II for 2021

Retrieved on: 
Wednesday, August 4, 2021
Articles, Academic disciplines, Artificial intelligence, Computational neuroscience, Science and technology, Cybernetics, Image segmentation, Lionbridge, Artificial general intelligence, Computer vision

PALO ALTO, Calif., Aug. 4, 2021 /PRNewswire-PRWeb/ -- In its second Hot Vendors report of the year, Aragon Research Inc. identifies emerging vendors in two markets: Computer Vision and Content Experience.

Key Points: 
  • PALO ALTO, Calif., Aug. 4, 2021 /PRNewswire-PRWeb/ -- In its second Hot Vendors report of the year, Aragon Research Inc. identifies emerging vendors in two markets: Computer Vision and Content Experience.
  • Computer vision is technology that uses artificial intelligence to intelligently recognize the content of an image or video.
  • It involves the labeling, segmentation, recognition, and ordering of visual content for use in an application.
  • Aragon Research identifies five Hot Vendors in computer vision that stand out for 2021: Arturo, Chooch AI, Lionbridge AI, Owl Autonomous Imaging, and Scale AI.

Augmentir Announces New Product Features to Extend Leadership Position in AI-based Performance Optimization for Frontline Work

Retrieved on: 
Wednesday, August 4, 2021
Articles, Academic disciplines, Artificial intelligence, Computational neuroscience, Cybernetics, Benchmark

The company announced the release of several new product features which improve and expand the in-app AI insights that deliver performance optimization opportunities to any industrial company with frontline workers.

Key Points: 
  • The company announced the release of several new product features which improve and expand the in-app AI insights that deliver performance optimization opportunities to any industrial company with frontline workers.
  • New AI-derived True Benchmark Using the highly granular data from work execution, Augmentir's AI predicts ideal execution times for each work process, quantifying the productivity opportunity across all frontline work activities and helping companies better evaluate performance improvement efforts.
  • To learn more about Augmentir and how its AI-powered connected worker platform is delivering performance optimization for industrial companies, visit augmentir.ai .
  • [1]Gartner, "Innovation Insight for the Connected Factory Worker", Simon Jacobson, Dana Stiffler, 9 April 2021
    View original content to download multimedia: https://www.prnewswire.com/news-releases/augmentir-announces-new-product...

Symbiance AI Announces revolutionary product to automate the writing of Clinical Study Report (CSR) and other scientific documents.

Retrieved on: 
Wednesday, August 4, 2021
Articles, Academic disciplines, Computational neuroscience, Artificial intelligence, Cybernetics, Artificial general intelligence, Medical writing

PRINCETON, N.J., Aug. 4, 2021 /PRNewswire/ --Symbiance AI, today announced the launch of its Artificial Intelligence (AI) powered product ZYLiQ which accelerates medical writing.

Key Points: 
  • PRINCETON, N.J., Aug. 4, 2021 /PRNewswire/ --Symbiance AI, today announced the launch of its Artificial Intelligence (AI) powered product ZYLiQ which accelerates medical writing.
  • This launch reflects Symbiance's growth ambitions and passion to answer certain challenges within clinical research by leveraging the power of AI.
  • ZYLiQ is a revolutionary product that automates 60-70% of CSR writing, adhering to regulatory and ICH E3 guidelines, reduction in the number of reviews, and ultimately saving time & cost.
  • Symbiance AI is a division of Symbiance Inc., a global CRO founded in 1990 with extensive clinical research expertise and global reach.